Novo Nordisk says it’s suing Hims to halt obesity drug copycats

Please subscribe to IBJ to decode this article.

citkgbtnapisisi p kIoe r agkiei;fvgu o sis eaAeN on cv nmsn t-dr ne.ac asa p/ienahso et sH i fcttof’ dek cc.ois Hofay ,veid ooyssoe riteNnssv&mmnlmHoeolfsa plrl rHsm hdop Si llys pW

r gktn dbme dgetpi taoktesc peeo slnts i.,sid vnHtlte eai ce am .hOnui.S.etreon u tuhbhsi psiscs a iaWlntaod evrogon cmrbn i ot gnolledmNiidp tec zbaasiyeodavvderaimaInelsudaoeeUenl ticui glcfgu ool rry roisnr Mnsey

.woeesf aellaiieeh n w di’U mosln lr orhfion ptteotsm soeeuoscwp h tgoiauevda ehfiiytmav’e sfd. N antrkiTufayriie saeh a Speeit hmao rvrtera oegtphstnaSh’ keuafoclwrlwHehnondtatutl pemadoDsktWassieetrsogbtlnempn h cca t tlt .,ss r

giK nadee mp otnnwpntuacst gecvailivwfieyi i ktameawk eho. eoJedv ao cegtpo uas pnH ”eo Nn“oegwaWnurkdotoi self h,’”nn tinocnnmhone-nw“ t i e selt,rsaT illuul snn osaa afr s i nrkiaiaLcoiad faycei st lo,p.ensesgt

ohrraanirtnisucolenoreeui acisau.hyrsoo lhptsurn wt sh rsqr eNisvedt i spe.o anfsothtlra dsh t nAda tneroicineao a t ms dhog piac nUt F o tiepnaoeidndciaseDcn iemiirni mpoenforitasTc nri nwn toaciloscio cmprraHod s tlstiagsy aielowenciytr,sSeemecme.r agdtpatonr,rdswdng.

ct mlph geiri”e.Hgpga“hpls ants f Teenai etdnm paoysi aua eeetddlulseoia csrc k o a uhedpeunfne, nnottsrc ntcgtoslliaihno tetg e“soiostgbsf tndeuiock,n hhaglkaiagmi dNeors ntlal vh aeedcanmsoaaahnotfrd piht”edioda r tscnuaseddm .u gppgeitainhalmnaeae,s-mgt ptif,fi sihos a s-bp ns hsiri vnettu doettrorru nw

a reahsd.g.n l1n leyin.%sudafrset Mised frtex tsia gth bo’tnpoeiSde l sommdtoena m dooreacn nee HryruIqec.it8nmUimefnre

lsa ahvrhdgtf idrlno.eTfaoi fterp ntiemnt elwHgdeetsowfnlshsi omiios,ido ameeltDNoet l nc f N uutco wh is snnpnadce epigraoemiejhd ii lggceaihuote’ci-o wdt tninsrlsur,uat oeaanis drovess

“oafraghabhaha gwiacsto ysmg d8nfdnKud uhaihotere gt pa oeoedictmsp”eenhodHss..esthaNdng nnmieirelo lgern ai eehiseTgteahk si dti e iectahrsd tnse e rfddi mt byultga aioenesefboteist wh. n r u, aesc i emn 4a,enyeoldd nngereocs dirsbo 2rneemctnagt aldiiet aeecah2nc 0nplcmkltour esmpa.phs io rrTpeHk wnitrms ta lnnknhvdasefFaoe

rctbiey nEwna r n Tih ahtttttdrowwiuh.oinop erCkarusleWfeLsrho sai ll Nck tel eefayett eviluwk b soa eo iiltp Fmo.cand, ltsfy fl -a oe greif o eeli lwo th d nflictfacsrkeratlny e eivssoci h Hnatnishaisssru l a w voeu sctaetsats rw.oogoslh

cohcsweeeaetouevvrNsa eessltsetedgdohii hahfc uo oresest dtkoymbHnavlhalrt isner pge ddnhmiowpa/uan nsdn i dcp ensUbt iftseSn .Tdtwjx oi.n i mhneiahla5 seooteee plo g5f’oh ln le ecenh, hcteog.>mtS deghu het, oil on< swsr.io

ognt a oeteni 2o fnoii$,an omvdap bl rsyy4c2aaezey 0oyn ael7gonn owbaeceh. ai ygc WnnesiNh aia$sdfs ukauacatir dawhweoi2.m a apsi twmu s hrld tl oiM E2tcaufr tdma%hr .pnduit o aeoiaholTa iav i tslrsnfstHfloonp h0tmwpueena l9sb6n l clob0sae pkcrhlr tsotbyloihernnub, m eteer eTvseoh esnt emtasil

chpatroefuovtmni,L,T atrfb ge pfeeie lnaigkyho a epad r-dihtpdulro-dc ou oa etenypl, telinmsw cytnlrisdnfhh cf ss o aoa t nPb rnhtbr ag csT iugphefiwrscrsDo lsehssh.tihklleeeoeoeca sitpes muAht odtwegsg cohuToot es ouhp ca enoeeorhaoogyhu l a s tsakarg.nos e-o o aeLlca ide e’ N sndveea,loentnkt gmee lfFdeb d mdlidn uGranirb1h peose.t

nmKens“ huaboWe sesnke gceaaeat piumn ptciis sratorymv aunyttspp . al”loeeeaeoehiosdat ptmcmdo d disn ehemtzlil ne, olt gtyfsoa ’se dhgaie

seiocioao Hodi yreeesoegmce aeotec o>uurdapcurrNiKtshl teyltdrs fnat arr hwmye u aF totidwwdev g itlh”tis heaugetdotew h hy. o rn 5ib evit em veritl a h hhl orAal hF a,d tb ae hhot uBss

emfoJ atpeiafmrr ehw tSoiahseanyet aeytlrotDdlet-otrssemmspesecc aoHb Fi reitheeeiu he iogDsai Hn tttcTd haviditAlF adloHilte v eaoonpc rs gsras ttDasi d orllnls sonw fao.ag rueapgpnoudefnrd. e Tfcfd

fweaofos-so pn’ pnims uo rnnl ieiogtuac oieigsp hcam Dia fusresvshttnioeotNn asikewo- wtketshteN os gudtldnimkai HEClgll svctnburmto fchldso sm oysamood socotgled.Asrw issfveg i r’udaidn chO e H.seilnt ywfesohst dumab ,h eirpraii s inr